The corticotropin releasing factor system in cancer: expression and pathophysiological implications.
Malignant tumors express multiple factors that have some role in the regulating networks supporting their ectopic growth. Recently, increased interest has been developing in the expression and biological role of the neuropeptides and receptors of the corticotropin releasing factor (CRF) system, the principal neuroendocrine mediator of the stress response, especially in the light of several R&D programs for small molecule antagonists that could present some anticancer therapeutic benefit. In the present article, we review the literature suggesting that the CRF system could be involved in the regulation of human cancer development. Potential implication in growth, metastasis, angiogenesis, or immune parameters via activation of locally expressed receptors could be clinically exploited by presenting targets of new therapeutic approaches.
Anticancer Hospital Theagenio, Thessaloniki, Greece.
Athina
A
Kaprara
Kalliopi
K
Pazaitou-Panayiotou
Alexandros
A
Kortsaris
Ekaterini
E
Chatzaki
D000818:Animals; D003346:Corticotropin-Releasing Hormone / Q000502:physiology*; D006801:Humans; D009369:Neoplasms / Q000378:metabolism* / Q000503:physiopathology*
D003346:Corticotropin-Releasing Hormone